Suchergebnisse - "Miura, Masaru"

PubPharm (6)

1

Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE) : a multicentre, prospective cohort study

enthalten in: The Lancet. Child & adolescent health | 2018

von Miyata, K. | Kaneko, T. | Morikawa, Y. | +15

2

Bradycardia Associated with Prednisolone in Children with Severe Kawasaki Disease

enthalten in: The Journal of pediatrics | 2017

von Nagakura, A. | Morikawa, Y. | Sakakibara, H. | +1

3

High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone

enthalten in: Endocrine journal | 2015

von Goto, M. | Miyagawa, N. | Kikunaga, K. | +2

4

Early and frequent development of ocular hypertension in children with nephrotic syndrome

enthalten in: Pediatric nephrology (Berlin, Germany) | 2014

von Kawaguchi, E. | Ishikura, K. | Hamada, R. | +9

5

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study) : a randomised, open-label, blinded-endpoints trial

enthalten in: Lancet (London, England) | 2012

von Kobayashi, T. | Saji, T. | Otani, T. | +120

CommentIn: Lancet. 2012 Apr 28;379(9826):1571-2. - PMID 22405252

6

Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease

enthalten in: The Pediatric infectious disease journal | 2009

von Kobayashi, T. | Inoue, Y. | Otani, T. | +8

1
[1]